Cost of disorders of the brain in Europe 2010

Anders Gustavsson, Jes Olesen(Glostrup Hospital), Martín Knapp(London School of Economics and Political Science), Brenda Gannon(University of Leeds), Carlo Faravelli(University of Florence), Linus Jönsson(Karolinska Institutet), Lars Jacob Stovner(Norwegian University of Science and Technology), Mikael Svensson(Karlstad University), Laura Fratiglioni(Karolinska Institutet), Korinna Karampampa, Amir Musayev, Maura Pugliatti(University of Sassari), Weili Xu(Karolinska Institutet), Jim van Os(King's College London), Richard Dodel(University of Duisburg-Essen), Martin Preisig(Goethe University Frankfurt), Jean‐Michel Vallat(Université de Limoges), Roland Simon(European Monitoring Centre for Drugs and Drug Addiction), Tobias Kurth(École Polytechnique Fédérale de Lausanne), Gisela Kobelt(Lund University), Poul Jennum(University of Copenhagen), Hans‐Christoph Steinhausen(University of Basel), Peter Van den Bergh(Cliniques Universitaires Saint-Luc), Andreas Maercker(University of Zurich), Mattias Linde(Norwegian University of Science and Technology), Brigitte Schlehofer(German Cancer Research Center), Christer Allgulander(Karolinska Institutet), Albena Jordanova(University of Antwerp), Frank Jacobi(Technische Universität Dresden), David Hilton Jones(John Radcliffe Hospital), Beatrice Melin(Umeå University), Ettore Beghi(Mario Negri Institute for Pharmacological Research), Hans‐Ulrich Wïttchen(Ludwig-Maximilians-Universität München), Massimo Moscarelli, Christina Ljungcrantz, Mattias Ekman, Juergen Rehm(Technische Universität Dresden), Roselind Lieb(University of Basel), Fiona Norwood(King's College Hospital), Luis Salvador‐Carulla(University of Canberra), B Jönsson(Stockholm School of Economics), Jordi Alonso(World Federation for Mental Health)
European Neuropsychopharmacology
September 15, 2011
Cited by 1,729


Related Papers